PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Education key to curbing antimicrobial resistance in cats

2023-11-07
(Press-News.org) ITHACA, N.Y. -- Better education for cat owners, more communication from veterinarians, increased drug choices and cheaper, rapid diagnostic tools can help improve antimicrobial use in cats, which has important implications for rising antimicrobial resistance in animals and humans, according to two new papers by Cornell researchers.

Antimicrobial resistance threatens up to 10 million human lives a year and may cost the global economy trillions of dollars, with resistant pathogens moving easily between humans and animals, according to the papers’ authors.

In one paper, “Divergent Veterinarian and Cat Owner Perspectives are a Barrier to Reducing the Use of Cefovecin in Cats,” published online Nov. 1 in the Journal of the American Veterinary Medical Association (JAVMA), the researchers conducted surveys to tease apart how cat owners’ and veterinarians’ views may each be contributing to overuse of the only long-acting, injectable antimicrobial for use in cats, called cefovecin.

While cefovecin is broad-spectrum and more convenient to administer, oral antimicrobials can be cheaper, more narrow-spectrum and provide a shorter length of treatment. That’s important because long-term exposure to antibiotics gives pathogens more opportunities to gain resistance.

“I could give only three to five days of pills for a urinary tract infection versus an injection of cefovecin, which lasts for seven or more days at effective concentrations, but persists at subtherapeutic levels for two months,” said lead author of the study, Casey Cazer, DVM ‘16, Ph.D. ’20, an assistant professor in the Department of Clinical Sciences and the associate hospital director of the Small Animal Community Practice Service in the College of Veterinary Medicine (CVM).

It can be a challenge to get cats to take oral medications, though veterinarians believe cat owners struggle more than they do. According to the survey, veterinarians estimated that 60% of cat owners found it difficult to medicate their cats and 20% found it impossible. On the other hand, fewer cat owners reported having at least one cat for whom they struggled to administer pills (31% reported difficulty and 9% found it impossible) or liquid medications (20% reported difficulty and 5% said it was impossible).

“If veterinarians are thinking ‘most of my clients can’t medicate their cats,’ then they are more likely to give the more intense, ‘bigger gun’ [the shot of cefovecin],” said Amelia Greiner Safi, M.S. ‘06, a professor of social and behavioral sciences and public health practice in the Department of Public and Ecosystem Health(CVM), who is a senior author of the paper.

The survey also revealed that some veterinarians believed older cat owners would struggle with administering oral medications, a bias not backed up by cat owners themselves.

When cat owners did struggle to restrain their cats or got scratched and couldn’t  administer oral medication, only 65% talked to their veterinarians afterwards about how to better give their cats medication, even though they generally trusted their veterinarians  as sources of information about cat health.

“If there’s an area where we can help veterinarians anticipate cat owner needs, because cat owners might not communicate, we can be proactive in training cat owners and help them  be more successful in giving oral medication that is less problematic for antibiotic resistance,” Cazer said.

Importantly, cat owners were also open to being educated about risks and benefits of different antibiotics. Given a choice between an injection, pills or liquid, about three in four cat owners said they preferred the injection. But when they were then informed that the injection could lead to antimicrobial resistance that threatens animals and humans, three in four were willing to try an oral medication.

“It highlights that we can, as veterinarians, educate cat owners and help them make better choices when it comes to antibiotic use,” Cazer said. A simple demonstration in restraining and successfully administering oral medications could reduce cefovecin use, according to the authors.

Veterinarians’ understanding of their own role in the problem of antimicrobial resistance varied, with some knowing the general risks but downplaying their own roles in contributing to it. Previous research has shown that the general public has a limited understanding of antimicrobial resistance.

Veterinarians also reported that they may succumb to giving cefovecin when they are concerned about comorbidities in older cats, when clients refuse expensive diagnostic tests, when they are uncertain about treatments, and when clients are pushy.    

Diagnostic testing guides proper antibiotic choices and is a vital tool for antimicrobial stewardship. Veterinarians and clients may decline testing because it is time consuming and costly, averaging close to $160 for a bacterial culture and sensitivity test in 2021. Without testing, cefovecin can be perceived as the simplest alternative, even if not ideal.

A companion overview paper led by Cazer and Safi, “Pathways to Sustainable Antimicrobial Use in Cats,” published Nov. 1 also in JAVMA, provides an overview of the issues and ways to prevent antimicrobial resistance. These include faster, cheaper diagnostic testing, development of new antimicrobials and better education and training of veterinarians and cat owners.

Co-authors on both papers include Ameila Frye M.P.H. ‘23,  and Lecsy Gonzalez M.P.H. ‘23, and research assistant Jeanne Lawless Ph.D. ‘93, in the Department of Public and Ecosystem Health. Claudia Cobo-Angel, a postdoctoral researcher (CVM), is a co-author of the overview paper.

The research was funded by a Cornell University Department of Public and Ecosystem Health Impact Award.

-30-

END


ELSE PRESS RELEASES FROM THIS DATE:

New compound shows early promise for treatment of Lou Gehrig’s disease in preclinical models

New compound shows early promise for treatment of Lou Gehrig’s disease in preclinical models
2023-11-07
In science, a simple but thorough observation can kick-start the most surprising findings. Researchers at the Hollings Cancer Center at the Medical University of South Carolina noticed that mice lacking a protein of interest in cancer research were showing visible signs of abnormal motor functions as they aged, including loss of coordination and strength. The team showed that that lack of this protein resulted in the accumulation of damaged mitochondria that affected motor function. Treating these mice with a drug that triggered the destruction of damaged mitochondria restored their motor ...

Diverse task force develops new quality measures to improve lupus care by 2030

2023-11-07
ATLANTA — Leaders of a project to develop and implement equitable new quality measures for lupus care by the end of the decade will present their work at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting (Abstract #1899). Systemic lupus erythematosus (SLE, lupus) is an autoimmune disease marked by adaptive immune system activation, formation of autoantibodies, and systemic inflammation affecting organ systems throughout the body. Lupus disproportionately affects women and people of color, who are more likely to have severe ...

Study finds low anti-Ro titers are not associated with fetal heart block

2023-11-07
ATLANTA - New research from an ongoing study that will be presented at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting, shows that pregnant women with very low titers of anti-Ro antibodies are at minimal to no risk of fetal atrioventricular (AV) block, a serious disorder affecting the heart’s electrical system. After birth, fetal AV block requires lifelong pacemaker treatment or cardiac transplantation and may be fatal. However, pregnant patients with higher titer antibodies seem to be at greatest risk  at risk ...

Study finds hydroxychloroquine lowers risk of nonalcoholic fatty liver disease in rheumatoid arthritis patients

2023-11-07
ATLANTA - New research at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting, shows that treating rheumatoid arthritis with hydroxychloroquine (HCQ) reduced the risk of nonalcoholic fatty liver disease, especially in women and men who are 50 years old and younger (Abstract #0396). Rheumatoid arthritis (RA) is a systemic autoimmune inflammatory disease marked by chronic joint inflammation leading to joint damage and loss of function. It can also affect tissues and organs outside the joints, including (but not limited to) the eyes, ...

Study shows saliva gland abnormalities in Sjögren's worsens over time

2023-11-07
ATLANTA - New research at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting, shows that ultrasound-detected salivary gland abnormalities in primary Sjögren's become more severe over time and that the slow-to-progress disease likely starts long before it is first detected (Abstract #1371).    Sjögren's disease also known as Primary Sjögren’s syndrome, is a systemic autoimmune disorder. It is marked by inflammation of the lacrimal and salivary glands, leading to chronic dry eyes and mouth. Fatigue is common, ...

Study finds positive antiphospholipid antibodies raises cardiovascular disease risk in patients with systemic lupus erythematosus

2023-11-07
ATLANTA — New research at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting, describes a link between positive antiphospholipid antibodies and an increased risk of future cardiovascular disease in patients with systemic lupus erythematosus (SLE) (Abstract #0552). Antiphospholipid antibodies (aPLs) are autoantibodies directed against phospholipid-binding proteins. In antiphospholipid syndrome, they are associated with heart attack, stroke, and pulmonary embolism, and with miscarriage and stillbirth during pregnancy. People with SLE also have a greatly increased risk ...

Study finds JAK inhibitors and tocilizumab effective in VEXAS syndrome

2023-11-07
ATLANTA - New research at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting, found that JAK inhibitors (JAKi) and tocilizumab elicited better response rates in VEXAS syndrome compared to other targeted therapies (Abstract #L03). VEXAS syndrome is a rare and often fatal autoimmune condition caused by a mutation in the UBA1 gene. It is marked by widespread inflammation leading to a range of symptoms that affect the skin, lungs, blood vessels and joints. The name is an acronym for disease characteristics: vacuoles in bone marrow, E1 enzyme (the enzyme encoded by the UBA1 gene), ...

Rheumatology training program for Native American primary care physicians expands reach

2023-11-07
ATLANTA — New research at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting, describes the expansion of a novel program to train primary care physicians (PCPs) in the diagnosis and management of rheumatoid arthritis (RA) in Native American communities that have little or no access to rheumatology care (Abstract #2455). Despite the high prevalence of RA and other rheumatologic diseases among Native Americans, many Native American communities lack adequate access to subspecialized care. As a result, responsibility for treatment has shifted to primary care providers, who often do not feel confident prescribing RA medications or ...

Study finds TNF blockers are not associated with poor pregnancy outcomes

2023-11-07
ATLANTA — According to new research at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting, continuing tumor necrosis factor inhibitors during pregnancy is not associated with worse fetal or obstetric outcomes and may reduce the risk of severe maternal infections during pregnancy (Abstract #0477). Tumor necrosis factor (TNF) inhibitors such as adalimumab and infliximab are often prescribed for inflammatory forms of arthritis that have not improved with other treatments. Although studies suggest the drugs are safe during pregnancy, ...

Researchers identify incidence and risk factors for new-onset interstitial lung disease in systemic sclerosis

2023-11-07
ATLANTA - New research at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting, reports the incidence and risk factors for new-onset interstitial lung disease (ILD) in previously ILD-negative systemic sclerosis patients (Abstract #1700). Interstitial lung disease is a common complication and cause of death in systemic sclerosis (SSc, scleroderma). Although the prevalence and risk factors for ILD are well known, less is known about the annual incidence and risk factors associated with the disease that occurs in patients who test negative on screening tests conducted at baseline. To answer these questions, Liubov Petelytska, ...

LAST 30 PRESS RELEASES:

Personalized brain stimulation shows benefit for depression

AI uncovers hidden rules of some of nature’s toughest protein bonds

Innovative approach helps new mothers get hepatitis C treatment

Identifying the Interactions That Drive Cell Migration in Brain Cancer

ORNL receives 2025 SAMPE Organizational Excellence Award

University of Oklahoma researchers aim to reduce indigenous cancer disparities

Study reveals new evidence, cost savings for common treatments for opioid use disorder in mothers and infants

Research alert: Frequent cannabis users show no driving impairment after two-day break

Turbulence with a twist

Volcanic emissions of reactive sulfur gases may have shaped early mars climate, making it more hospitable to life

C-Path concludes 2025 Global Impact Conference with progress across rare diseases, neurology and pediatrics

Research exposes far-reaching toll of financial hardship on patients with cancer

The percentage of women who went without a Pap smear for cervical cancer screening increased following the COVID-19 pandemic, from 19% in 2019 to 26% in 2022

AI tools fall short in predicting suicide, study finds

Island ant communities show signs of ‘insect apocalypse’

Revealed: The long legacy of human-driven ant decline in Fiji

Analyzing impact of heat from western wildfires on air pollution in the eastern US

Inadequate regulatory protections for consumer genetic data privacy in US

Pinning down protons in water — a basic science success story

Scientists reveal how the brain uses objects to find direction

Humans sense a collaborating robot as part of their “extended” body

Nano-switch achieves first directed, gated flow of chargeless quantum information carriers

Scientist, advocate and entrepreneur Lucy Shapiro to receive Lasker-Koshland special achievement award

Creating user personas to represent the needs of dementia caregivers supporting medication management at home

UTIA participates in national study analyzing microbial communities, environmental factors impacting cotton development

Mizzou economists: 2025 farm income boosted by high cattle prices and one-time payments

What 3I/ATLAS tells us about other solar systems

University of Cincinnati allergist receives $300,000 grant to research rare esophageal disease

Ohio State scientists advance focus on nuclear propulsion

New study reveals a hidden risk after cervical cancer

[Press-News.org] Education key to curbing antimicrobial resistance in cats